Continuing the Search for Knowledge


Read Article
  • Glaucoma 360 Fosters Collaboration With Industry

    Read Article


Visit @GlaucomaToday on Twitter

Articles From This Issue


Continuing the Search for Knowledge


By Arsham Sheybani, MD One of the most challenging yet essential parts of practicing medicine, especially in the field of glaucoma, is staying current while not gettin…

The Education Evolution


This issue marks the beginning of GT’s 15th year. It is the first recurring news publication devoted to advancing the care of glaucoma patients. In January 2003, the…

The Literature


The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes Christakis P, Kalenak J, Tsai JC, et al1 ABSTRACT SUMMARY This prospective, randomized, internation…


GlaucomaToday Polls

View All



Peer-Reviewed Paper Demonstrates the Benefits of Dropless Cataract Surgery

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, today announced the publi…

Ocular Therapeutix Announces FDA Acceptance of NDA Resubmission for Dextenza for…

Ocular Therapeutix announced that the company’s new drug application (NDA) resubmission for De…

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Facebook Twitter

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.